The Latest Breaking News from FSE

Rangers have released a statement highlighting concerns over the treatment of supporters who had travelled to Seville to watch the game and have urged those there to share their experiences.

RANGERS have expressed their 'major concerns' over the treatment of supporters at the Europa League final and urged fans to come forward to raise…

Novamind Inc. (OTCQB:NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ:MNMD) (NEO:MMED) to host a Phase IIb randomized clinical trial investigating lysergic acid diethylamide (LSD) for generalized anxiety disorder in adults.

Novamind Inc. (OTCQB:NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an aggregate of 325,000 restricted share units effective March 11, 2022, to certain executives and employees of the company pursuant to its restricted share unit plan. The RSUs will vest in 25% intervals, every 6 months from…

Novamind Inc. (OTCQB:NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major depressive disorder sponsored by the Usona Institute. The company completed first patient randomization at its Draper, Utah research site.

High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA) has launched its cannabis Delivery on Demand program at select Canna Cabana locations in Alberta.

High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA) has launched cannabis Delivery on Demand in select Canna Cabana retail locations across Canada.

Mental health company specialized in psychedelic medicine Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE:HN2) has been selected by the Ketamine Research Foundation to host a phase II clinical trial investigating ketamine-assisted psychotherapy (KAP) for adults with life-threatening illness.